We observed that human Ewing’s sarcoma cells subjected to EWS shRNA plasmid transfection and TFL treatment failed to produce the potent angiogenic factors VEGF and b-FGF, indicating efficacy of this combination therapy in blocking angiogenesis. This evidence concerns the gene FGF2 and Ewing sarcoma.